Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 31;183(9):973-981.
doi: 10.1001/jamainternmed.2023.3087. Online ahead of print.

Aortic Stenosis Risk in Rheumatoid Arthritis

Tate M Johnson  1   2 , Chetaj A Mahabir  3 , Yangyuna Yang  2 , Punyasha Roul  2 , Andrew M Goldsweig  4 , Bryce A Binstadt  5 , Joshua F Baker  6   7 , Brian C Sauer  8   9 , Grant W Cannon  8   9 , Ted R Mikuls  1   2 , Bryant R England  1   2
Affiliations

Aortic Stenosis Risk in Rheumatoid Arthritis

Tate M Johnson et al. JAMA Intern Med. .

Abstract

Importance: Although an increased risk of ischemic cardiovascular disease has been associated with rheumatoid arthritis (RA), the risk of aortic stenosis (AS) is unknown.

Objective: To examine the risk of incident AS, aortic valve intervention, AS-related death, and risk factors for AS development in patients with RA.

Design, setting, and participants: This cohort study linked data from the Veterans Health Administration (VHA) and Centers for Medicare & Medicaid Services from 2000 to 2019. Patients with RA were matched by age, sex, and VHA enrollment year with up to 10 patients without RA. The cohort was followed until incident AS, aortic valve intervention, or death. Data were analyzed from August 23, 2022, to March 3, 2023.

Exposures: the primary exposure was the presence of RA, defined using validated RA algorithms.

Main outcomes and measures: Aortic stenosis was defined as a composite of inpatient or outpatient diagnoses, surgical or transcatheter aortic valve replacement, or AS-related death using diagnostic and procedural codes. Risk of AS development was assessed with multivariable Cox proportional hazards models adjusted for race, ethnicity, smoking status, body mass index, rurality, comorbidities, and health care use.

Results: The cohort included 73 070 patients with RA (64 008 [87.6%] males; mean [SD] age, 63.0 [11.9] years) matched with 639 268 patients without RA (554 182 [86.7%] males; mean [SD] age, 61.9 [11.7] years) and 16 109 composite AS outcomes that occurred over 6 223 150 person-years. The AS incidence rate was 3.97 (95% CI, 3.81-4.13) per 1000 person-years in patients with RA and 2.45 (95% CI, 2.41-2.49) per 1000 person-years in the control patients (absolute difference, 1.52 per 1000 person-years). Rheumatoid arthritis was associated with an increased risk of composite AS (adjusted hazard ratio [AHR], 1.48; 95% CI, 1.41-1.55), aortic valve intervention (AHR, 1.34; 95% CI, 1.22-1.48), and AS-related death (AHR, 1.26; 95% CI, 1.04-1.54).

Conclusions and relevance: In this cohort study, RA was associated with a higher risk of developing AS and the subsequent risks of undergoing aortic valve intervention and suffering from AS-related death. Future studies are needed to confirm whether valvular heart disease, specifically AS, may be an overlooked cardiovascular disease complication in RA.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Johnson reported receiving grants from Rheumatology Research Foundation during the conduct of the study. Dr Goldsweig reported receiving personal fees from Edwards Lifesciences for speaking honorarium outside the submitted work. Dr Binstadt reported receiving grants from Sobi and Pfizer outside the submitted work. Dr Baker reported receiving consulting fees from CorEvitas and Cumberland Pharmaceuticals outside the submitted work. Dr Mikuls reported receiving grants from the US Department of Veterans Affairs and Horizon Therapeutics; personal fees from Horizon Therapeutics, Pfizer, and Sanofi outside the submitted work; and royalties from UpToDate and Elsevier outside the submitted work. Dr England reported receiving grants from the US Department of Veterans Affairs during the conduct of the study and personal fees from Boehringer Ingelheim outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. Risk of Aortic Stenosis, Aortic Valve Intervention, and Aortic Stenosis–Related Death in Patients With Rheumatoid Arthritis
Forest plot illustrates the adjusted hazard ratios (AHRs) and 95% CIs for risk of incident aortic stenosis and aortic stenosis–related outcomes in patients with rheumatoid arthritis compared with matched patients without rheumatoid arthritis. Estimates are from multivariable Cox proportional hazards regression models, stratified on matched pairs and adjusted for race, ethnicity, body mass index, smoking status, comorbidity burden, and health care use. SAVR indicates surgical aortic valve replacement; TAVR, transcatheter aortic valve replacement.
See this image and copyright information in PMC

References

    1. England BR, Sayles H, Michaud K, et al. . Cause-specific mortality in male US veterans with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2016;68(1):36-45. doi:10.1002/acr.22642 - DOI - PubMed
    1. Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol. 2008;26(5)(suppl 51):S35-S61. - PubMed
    1. England BR, Thiele GM, Anderson DR, Mikuls TR. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ. 2018;361:k1036. doi:10.1136/bmj.k1036 - DOI - PMC - PubMed
    1. Breed ER, Binstadt BA. Autoimmune valvular carditis. Curr Allergy Asthma Rep. 2015;15(1):491. doi:10.1007/s11882-014-0491-z - DOI - PMC - PubMed
    1. Bourgeois R, Bourgault J, Despres AA, et al. . Lipoprotein proteomics and aortic valve transcriptomics identify biological pathways linking lipoprotein(a) levels to aortic stenosis. Metabolites. 2021;11(7):459. doi:10.3390/metabo11070459 - DOI - PMC - PubMed

LinkOut - more resources